Form D · Biotechnology

LIVENTA BIOSCIENCE, INC.

West Conshohocken, PA · CIK 0001531247

Offering snapshot reported Oct 3, 2014 · SEC filing

Reported sold
$150K
Offering amount: $7.5M
Investors reported
7
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Sep 24, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 3, 2014Initial$150,000No comparison7SEC filing
Feb 7, 2013Initial$1,233,332No comparison3SEC filing
Dec 10, 2012Initial$1,000,000No comparison1SEC filing
Sep 28, 2011Initial$250,000No comparison3SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$975K (estimated)
Finders' fees
$0
Form D file number
021-225787

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Emergent Financial Group, Inc.37891Emergent Financial Group, Inc. · CRD 37891

Source: Form D, filed Oct 3, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Buche Executive
Olivier Carli Director
Dennis R Kuhns Director
Marc R. Viscogliosi Director
Jeffrey S White Director
Robin Young Director, Executive
Benjamin B. Young Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
100 Four Falls Corporate Center 1001 Conshohocken State Road, Suite 660
West Conshohocken, PA, 19428